Hrt Financial LP Royalty Pharma PLC Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $3.57 Million - $4.08 Million	130,188 New	130,188 $3.95 Million
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $6.8 Million - $8.12 Million	-258,823 Reduced 71.35%	103,916 $2.82 Million
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $10.7 Million - $13.3 Million	362,739 New	362,739 $11.2 Million
Q4 2022 Feb 10, 2023	BUY	$39.17 - $44.04 $4.69 Million - $5.27 Million	119,689 New	119,689 $4.73 Million
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $2.26 Million - $2.67 Million	60,283 New	60,283 $2.53 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $11.2 Million - $13.1 Million	-310,887 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $12.4 Million - $14.5 Million	310,887 New	310,887 $12.7 Million
Q3 2020 Nov 13, 2020	SELL	$38.56 - $48.36 $2.71 Million - $3.4 Million	-70,234 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $3.13 Million - $3.66 Million	70,234 New	70,234 $3.41 Million

398

291M

305K

138K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $12.3B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.